Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Schirra
Effects of Glucagon-Like Peptide-1(7-36)amide on Motility and Sensation of the Proximal Stomach in Humans
Gut
Gastroenterology
Endogenous Glucagon-Like Peptide 1 Controls Endocrine Pancreatic Secretion and Antro-Pyloro-Duodenal Motility in Humans
Gut
Gastroenterology
Related publications
Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Glucagon-Like Peptide-1-(7–36)-Amide on Pancreatic Islet and Intestinal Blood Perfusion in Wistar Rats and Diabetic GK Rats
Clinical Science
Medicine
Effect of Glucagon-Like Peptide 1(7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Normalization of Fasting Hyperglycaemia by Exogenous Glucagon-Like Peptide 1 (7-36 Amide) in Type 2 (Non-Insulin-Dependent) Diabetic Patients
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Inhibition of Carbohydrate-Mediated Glucagon-Like Peptide-I (7–36)amide Secretion by Circulating Non-Esterified Fatty Acids
Clinical Science
Medicine
Effects of Calcium Salts of Long-Chain Fatty Acids and Rumen-Protected Methionine on Plasma Concentrations of Ghrelin, Glucagon-Like Peptide-1 (7 to 36) Amide and Pancreatic Hormones in Lactating Cows
Domestic Animal Endocrinology
Animal Science
Zoology
Food Animals
Endocrinology
Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Cardiovascular and Hemodynamic Effects of Glucagon-Like Peptide-1
Reviews in Endocrine and Metabolic Disorders
Endocrinology
Metabolism
Diabetes
